NICE (National Institute of Health and Clinical Excellence) issued its draft guidance on 5 August 2011. The guidance stated that fingolimod is not recommended for the treatment of relapsing remitting multiple sclerosis. Read more here.
Friday, 2 September 2011
MS Trust expresses concerns about NICE guidance on fingolimod
NICE (National Institute of Health and Clinical Excellence) issued its draft guidance on 5 August 2011. The guidance stated that fingolimod is not recommended for the treatment of relapsing remitting multiple sclerosis. Read more here.
